882679-22-3 Usage
Uses
Used in Organic Synthesis:
3-Iodo-4-methyl-2-nitrobenzoic acid is used as a reagent or intermediate in chemical reactions to produce other organic compounds. Its unique structure allows it to be a versatile component in the synthesis of various organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Iodo-4-methyl-2-nitrobenzoic acid is used as a key component in the development of novel medications. Its chemical properties make it a promising candidate for the creation of new drugs with potential therapeutic applications.
Used in Materials Science:
3-Iodo-4-methyl-2-nitrobenzoic acid has potential applications in the field of materials science. It can be utilized in the production of specialty polymers or coatings, where its unique chemical properties can contribute to the development of innovative materials with specific characteristics.
Overall, 3-Iodo-4-methyl-2-nitrobenzoic acid is a versatile chemical compound with a wide range of applications across different industries, including organic synthesis, pharmaceutical research, and materials science. Its unique structure and properties make it a valuable asset in the development of new and innovative products.
Check Digit Verification of cas no
The CAS Registry Mumber 882679-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,6,7 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 882679-22:
(8*8)+(7*8)+(6*2)+(5*6)+(4*7)+(3*9)+(2*2)+(1*2)=223
223 % 10 = 3
So 882679-22-3 is a valid CAS Registry Number.
882679-22-3Relevant academic research and scientific papers
COVALENT INHIBITORS OF KRAS
-
, (2018/12/13)
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R1, R2a,
NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS AND METHODS OF USE
-
Page/Page column 72, (2008/06/13)
The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have Formula (I) wherein R1 is Formula (II), (III) or (IV) and A1, A2, A3, A4, X, Z, Z', R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
